Uritact DS Side Effects
Generic name: hyoscyamine / methenamine / methylene blue / phenyl salicylate
Note: This document contains side effect information about hyoscyamine / methenamine / methylene blue / phenyl salicylate. Some of the dosage forms listed on this page may not apply to the brand name Uritact DS.
Some side effects of Uritact DS may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Applies to hyoscyamine / methenamine / methylene blue / phenyl salicylate: oral capsule, oral delayed release tablet, oral tablet
Methylene blue will most likely cause your urine or stools to appear blue or green in color. This is a normal side effect of the medication and will not cause any harm.
Get emergency medical help if you have any of these signs of an allergic reaction while taking hyoscyamine / methenamine / methylene blue / phenyl salicylate: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using this medication and call your doctor at once if you have:
-
severe dizziness, blurred vision, fast heart rate;
-
agitation, confusion, feeling restless or excited;
-
painful or difficult urination; or
-
feeling short of breath.
Common side effects may include:
-
mild dizziness;
-
drowsiness; or
-
flushing (warmth, redness, or tingly feeling).
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
More Uritact DS resources
- Uritact DS MedFacts Consumer Leaflet (Wolters Kluwer)
- Darcalma Prescribing Information (FDA)
- Darcalma Concise Consumer Information (Cerner Multum)
- Darpaz Prescribing Information (FDA)
- Phosenamine Prescribing Information (FDA)
- Phosphasal Prescribing Information (FDA)
- Phosphasal Advanced Consumer (Micromedex) - Includes Dosage Information
- Prosed EC Advanced Consumer (Micromedex) - Includes Dosage Information
- Urelle Prescribing Information (FDA)
- Uribel Prescribing Information (FDA)
- Urimax delayed-release tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Urised MedFacts Consumer Leaflet (Wolters Kluwer)
- Uritact-EC delayed-release tablets MedFacts Consumer Leaflet (Wolters Kluwer)
- Ustell Prescribing Information (FDA)
- Uta MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


